Prelude Therapeutics Incorporated (PRLD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.06
Day's range
$3.46

Prelude Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 08/14/2026 13.72 M $73.15 M   25.81% 13.95%
BAKER BROS. ADVISORS LP 08/14/2026 10.12 M $53.96 M   0.00% 10.29%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 6.48 M $34.52 M   100.00% 6.58%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 3.38 M $18.01 M   100.00% 3.43%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 2.42 M $12.87 M   51.65% 2.45%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.01 M $10.71 M   63.32% 2.04%
BLACKROCK, INC. 08/07/2026 1.80 M $9.58 M   458.43% 1.83%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 1.02 M $5.44 M   82.65% 1.04%
TWO SIGMA INVESTMENTS, LP 08/14/2026 993.37 K $5.29 M   7.55% 1.01%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 900.90 K $4.80 M   489.50% 0.92%
MILLENNIUM MANAGEMENT LLC 08/14/2026 844.99 K $4.50 M   120.78% 0.86%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 841.86 K $4.49 M   178.34% 0.86%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 766.10 K $4.08 M   100.00% 0.78%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 611.36 K $3.25 M   19.52% 0.62%
MORGAN STANLEY 08/13/2026 503.86 K $2.69 M   56.40% 0.51%
STATE STREET CORP 08/07/2026 428.79 K $2.29 M   210.20% 0.44%
UBS GROUP AG 08/13/2026 318.80 K $1.70 M   394.22% 0.32%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 284.89 K $1.52 M   81.02% 0.29%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 281.20 K $1.50 M   2.18% 0.29%
NORTHERN TRUST CORP 08/13/2026 240.60 K $1.28 M   380.05% 0.24%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 193.92 K $1.03 M   100.00% 0.20%
MARSHALL WACE, LLP 08/13/2026 190.69 K $1.02 M   -46.87% 0.19%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 125.61 K $669.48 K   15.15% 0.13%
GOLDMAN SACHS GROUP INC 08/14/2026 120.83 K $644.05 K   -48.90% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 111.00 K $591.63 K   428.57% 0.11%
HILLSDALE INVESTMENT MANAGEMENT INC. 08/12/2026 81.40 K $433.86 K   100.00% 0.08%
BANK OF NEW YORK MELLON CORP 08/06/2026 68.19 K $363.44 K   100.00% 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 67.62 K $360.43 K   100.00% 0.07%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 67.62 K $360.43 K   100.00% 0.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 64.50 K $343.79 K   20.56% 0.07%
JANE STREET GROUP, LLC 08/14/2026 64.10 K $341.65 K   100.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 63.70 K $339.52 K   100.00% 0.06%
SQUAREPOINT OPS LLC 08/14/2026 59.54 K $317.35 K   100.00% 0.06%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 47.57 K $253.57 K   100.00% 0.05%
MARINER, LLC 08/13/2026 45.26 K $241.24 K   100.00% 0.05%
NUVEEN, LLC 08/11/2026 37.02 K $197.33 K   100.00% 0.04%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 35.21 K $186.84 K   0.00% 0.04%
INVESCO LTD. 08/14/2026 34.74 K $185.18 K   100.00% 0.04%
CERITY PARTNERS LLC 08/14/2026 32.88 K $175.22 K   0.00% 0.03%
STATE OF WYOMING 08/06/2026 32.86 K $175.15 K   100.00% 0.03%
CITADEL ADVISORS LLC 09/02/2026 31.30 K $166.83 K   100.00% 0.03%
GRAHAM CAPITAL MANAGEMENT, L.P. 08/14/2026 29.77 K $158.67 K   162.45% 0.03%
DEUTSCHE BANK AG\ 08/07/2026 27.82 K $148.30 K   100.00% 0.03%
WELLS FARGO & COMPANY/MN 08/14/2026 25.33 K $134.98 K   100.00% 0.03%
BANK OF AMERICA CORP /DE/ 08/14/2026 23.88 K $127.25 K   -57.76% 0.02%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 22.76 K $122.00 K   100.00% 0.02%
CITADEL ADVISORS LLC 09/02/2026 22.55 K $120.21 K   -81.87% 0.02%
RHUMBLINE ADVISERS 08/12/2026 22.07 K $117.65 K   100.00% 0.02%
JANE STREET GROUP, LLC 08/14/2026 20.10 K $107.13 K   100.00% 0.02%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 16.21 K $86.40 K   249.65% 0.02%

Prelude Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 99 institutional investors and hedge funds held shares of Prelude Therapeutics Inc. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 13.72 M

BAKER BROS. ADVISORS LP: 10.12 M

RA CAPITAL MANAGEMENT, L.P.: 6.48 M

Soleus Capital Management, L.P.: 3.38 M

Kynam Capital Management, LP: 2.42 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.01 M

50.48% of Prelude Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 54.17 M shares in the last 24 months. This purchase volume represents approximately $167.39 M in transactions.